NCT00509873

A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 578 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: 1 Year
• Healthy volunteers: Not accepted

Summary

The study will determine the safety and efficacy of gatifloxacin eye drops in patients with bacterial conjunctivitis

Conditions

• Bacterial Conjunctivitis

Interventions

Type	Name	Description
DRUG	Gatifloxacin 0.5% eye drops	Day 1 = 1 drop of study medication every 2hrs up to 8 times total; day 2-5 = 1 drop twice daily
DRUG	placebo eye drops	Day 1 = 1 drop of study medication every 2hrs up to 8 times total; day 2-5 = 1 drop twice daily

Timeline

• Start date: 2007-08-01
• Primary completion: 2008-06-01
• Completion: 2008-06-01
• First posted: 2007-08-01
• Last updated: 2011-11-30
• Results posted: 2011-11-30

Locations

1 site across 1 country: United States